NMPA Approval

Upadacitinib Sustained - release Tablets

Approval Number

国药准字HJ20220011

Registration Date

February 18, 2022

Drug Information

Generic Name

乌帕替尼缓释片

Trade Name

瑞福

Dosage Form

片剂

Strength

30mg（按C₁₇H₁₉F₃N₆O计）

Drug Type

化学药品

Registration Date

February 18, 2022

Expiry Date

February 17, 2027

Company Address

Knollstrasse, 67061 Ludwigshafen, Germany.

Company Address

Manorhamilton Road, Sligo, Ireland.

Empowering clinical research with data-driven insights and AI-powered tools.